The APACHE II score turns a snapshot of a patient's first 24 hours in intensive care into a single number that reflects how critically ill they are. Developed by Knaus and colleagues in 1985, it remains one of the most widely used severity-of-illness scores in critical care — for estimating mortality risk, comparing case mix between units, and stratifying patients in research.

How the APACHE II score works

APACHE II adds three parts. The Acute Physiology Score takes the worst value in the first 24 hours for 12 variables — temperature, mean arterial pressure, heart rate, respiratory rate, oxygenation, arterial pH, sodium, potassium, creatinine, hematocrit, white blood cell count, and the Glasgow Coma Scale — and scores each from 0 (normal) to 4 (extreme derangement). Age points add 0 to 6, and chronic health points add 2 or 5 when a patient has severe long-standing organ disease or an immunocompromised state. The three parts sum to a total from 0 to 71.

Two variables have special rules. The neurologic contribution is 15 minus the actual Glasgow Coma Scale, so a comatose patient contributes up to 12 points. And creatinine points are doubled when acute kidney injury is present, up to 8 points.

From score to mortality — and why it is approximate here

In the original study, a higher APACHE II score tracked closely with higher hospital mortality. The published death-rate table shows roughly 4% mortality at a score of 0–4 rising to about 85% at 35 or above for nonoperative patients, with lower rates for postoperative patients. This calculator reports those bands as an approximate reference range.

The fully validated APACHE II mortality equation is more specific: it adds a coefficient for the patient's admission diagnostic category (for example, sepsis, trauma, or post-CABG) on top of the score. That per-diagnosis weight cannot be reproduced faithfully in a general-purpose tool, so the numbers here should be read as a reference range rather than a precise per-patient prediction.

How it is used and its limits

APACHE II is a one-time score anchored to the first 24 hours; it is not designed to be recalculated daily like the SOFA score, which tracks organ dysfunction over time. It describes a population's expected mortality well but should never be used to make an individual treatment or withdrawal-of-care decision on its own. It also predates many modern therapies, does not capture frailty or specific diagnoses beyond the diagnostic-category weight, and depends on complete, accurate first-24-hour data. Treat the output as one input among many in a full clinical assessment.